- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05138640
Bone Strength and Physical Activity in Patients With a Recent Clinical Fracture
November 16, 2021 updated by: Joop P.W. van den Bergh
Prospective Evaluation of Bone Strength, Physical Activity, Falls, Subsequent Fractures and Mortality in Patients Presenting With a Recent Clinical Fracture
The risk for a subsequent fracture is significantly higher in patients presenting with a fracture compared to individuals without a previous fracture and is highest within the first 2 years after the initial fracture.
The risk for a subsequent fracture is not dependent of BMD as measured by conventional DXA.
In recent studies, it has been shown that HRpQCT measurements provide information about bone structure, bone quality and bone strength in addition to BMD measurements.
Diagnostic strategies should be focussed on bone quality and bone strength and fall prediction in the patients at high risk for falls, subsequent fracture and mortality such as patients with a recent fracture.
Therefore, the investigators conduct a prospective observational study in 500 patients aged 50 years and older who present with a clinical fracture for evaluation of bone strength, physical activity, falls, subsequent fractures and mortality during a follow-up period of 3 years.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Limburg
-
Venlo, Limburg, Netherlands, 5912BL
- Viecuri Medical Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with a recent fracture evaluated at the FLS at VieCuri MC Venlo
Description
Inclusion Criteria:
- Patients aged 50 years and older with a recent fracture that is being evaluated at the FLS at VieCuri MC.
- Patients who understand the conditions of the study and are willing and able to comply with the scheduled biochemical study procedures
- Patients who signed the Ethics Committee approved specific Informed Consent Form prior to inclusion.
Exclusion Criteria:
- Patients with malignancy metastatic to the bone.
- Patients with osteomyelitis.
- Patients with fractures due to failure of a prosthesis.
- Patients, who as judged by the Principal Investigator, are mentally incompetent. Patients who are compos mentis and understand the patient information, will not be considered mentally incompetent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bone strength assessed with HRpQCT
Time Frame: 3 years
|
Difference in bone strength, estimated by micro-finite element analyses, will be compared between patients with and without a subsequent fracture within 3 years of follow-up.
|
3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subsequent falls within 3 years after a fracture
Time Frame: 3 years
|
Number of patients sustaining a new fall during 3 years of follow-up.
|
3 years
|
|
Mortality
Time Frame: 3 years
|
Number of patients deceased during 3 years of follow-up
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: J PW van den Bergh, MD, PhD, Viecuri Medical Centre
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2014
Primary Completion (Actual)
July 1, 2019
Study Completion (Actual)
July 1, 2019
Study Registration Dates
First Submitted
September 26, 2014
First Submitted That Met QC Criteria
November 16, 2021
First Posted (Actual)
December 1, 2021
Study Record Updates
Last Update Posted (Actual)
December 1, 2021
Last Update Submitted That Met QC Criteria
November 16, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NL45707.072.13
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fractures, Bone
-
Jen-Chieh LaiCompleted
-
Lawson Health Research InstituteCompleted
-
Shahid Beheshti University of Medical SciencesRecruiting
-
Artur Salgado SANAMSARecruitingBone Loss | Bone Fractures | Bone Defects | Bone GraftPortugal
-
Brigham and Women's HospitalNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Active, not recruitingFractures | Bone Density | Bone HealthUnited States
-
AO Innovation Translation CenterActive, not recruitingLong Bone FracturesCanada, United States, Australia, Croatia, Chile, Spain, Venezuela, Ghana, Pakistan, Germany, India, Greece
-
University Hospital, Clermont-FerrandTerminated
-
IlluminOss Medical, Inc.CompletedHumerus Fracture Metastatic Bone DiseaseUnited States
-
Centre Hospitalier Universitaire Saint PierreRecruiting
-
McMaster UniversityMcMaster Surgical AssociatesCompleted
Clinical Trials on Not applicable. The study is designed as an observational cohort study
-
Shanghai Zhongshan HospitalCompleted
-
National University of SingaporeT3 Health PTE LTDNot yet recruitingAging | Obesity & OverweightSingapore
-
Finnish Institute for Health and WelfareNorwegian Institute of Public Health; Karolinska InstitutetActive, not recruitingSmoking | COVID-19 | Tobacco Use | Vaccination RefusalFinland
-
Royal Brompton & Harefield NHS Foundation TrustUnknownEvaluation of Speckle Tracking Parameters as Predictors of Successful VA SPECKLE ECMO (SPECKLE-ECMO)Cardiogenic ShockUnited Kingdom
-
MedicineJanssen Pharmaceuticals; National Medical Research Council (NMRC), SingaporeUnknown
-
Ludwig Boltzmann Institute for Lung HealthActive, not recruitingRespiration Disorders | Body Composition, Beneficial | Metabolic HealthAustria
-
European Foundation for the Care of Newborn InfantsNot yet recruitingSelf-Assessment | Development of a Tool to Assess the Level of Implementing the European Standards of Care for Newborn Health | Testing of the Developed Self-assessment Tool in European HospitalsGermany
-
Pemba Ministry of Health ZanzibarJiangsu Institute of Parasitic DiseasesNot yet recruiting
-
University of OxfordBrigham and Women's Hospital; University College, London; Liverpool Heart and... and other collaboratorsActive, not recruitingAtrial Fibrillation New OnsetUnited Kingdom
-
University of OxfordIntensive Care National Audit & Research CentreActive, not recruitingMyocardial Infarction | Heart Failure | Stroke | Critical Illness | Covid19 | Renal Failure | Deep Vein Thrombosis | Pulmonary EmbolismUnited Kingdom